Source: Annual Congress 2011 - Barrier functions in sepsis and acute lung injury
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Dreymueller, C. Martin, T. Kogel, F. M. Hess, C. P. Blobel, K. Horiuchi, S. Uhlig, A. Ludwig (Aachen, Germany; Tokyo, Japan; New York, United States Of America). Role of ADAM17 in endotoxin-induced pulmonary inflammation. Eur Respir J 2011; 38: Suppl. 55, 2941

Member's Comments

No comment yet.

Related content which might interest you: Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Eur Respir Rev 2006; 15: 207-208 Year: 2006 ADAM-8 metalloproteinase drives acute allergen-induced airway inflammation Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Role of IFNg in smoke-induced pulmonary emphysema and cachexia Source: Eur Respir J 2005; 26: Suppl. 49, 732s Year: 2005 Selective endothelin-A receptor blockade attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Sirtuins inhibition modulates endotoxin-induced lung inflammation Source: Annual Congress 2010 - Models of airways disease Year: 2010 Role of CD69 in the pathogenesis of elastase-induced pulmonary inflammation and emphysema Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Therapeutic hypercapnia prevents pulmonary hypertension in rats with bleomycin-induced chronic neonatal lung injury Source: Annual Congress 2011 - Resuscitation and ventilation in the baby and infant Year: 2011 Role of syndecan-4 in acute lung inflammation Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis Source: Eur Respir J 2012; 39: 141-148 Year: 2012 Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis Source: Eur Respir J 2011; 39: 141-148 Year: 2012 FIZZ1: a new pathway in silica-induced inflammatory mediators and pulmonary fibrosis Source: International Congress 2018 – Occupational and environmental lung diseases: mechanisms, biomarkers and causation Year: 2018 Is TGFb a central mediator in the development of pulmonary fibrosis? Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 Arginase inhibition modulates lung strip mechanics in animals with chronic pulmonary inflammation Source: Annual Congress 2008 - Pathophysiology of respiratory diseases Year: 2008 Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006 Role of IL-11 in vascular function of pulmonary fibrosis patients Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice Source: Eur Respir J 2012; 40: 1475-1482 Year: 2012 PBI-compound, a novel first-in-class anti-inflammatory/fibrotic compound, reduces bleomycin-induced pulmonary fibrosis by regulating inflammatory cytokines in bronchoalveolar fluid Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 102s Year: 2006 Ghrelin attenuates lipopolysaccharide-induced acute lung injury Source: Eur Respir J 2005; 26: Suppl. 49, 731s Year: 2005